BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23445199)

  • 21. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
    Kronbichler A; Bruchfeld A
    Nephron Clin Pract; 2014; 128(3-4):277-82. PubMed ID: 25401966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Choosing the right treatment approach in focal and segmental glomerular sclerosis with chronic renal failure].
    Valerio F; Sottini L; Turina S; Dallera N; Faberi E; Kenou R; Mazzola G; Scolari F
    G Ital Nefrol; 2008; 25 Suppl 44():S88-S98. PubMed ID: 19048592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab treatment for adult patients with focal segmental glomerulosclerosis.
    Ochi A; Takei T; Nakayama K; Iwasaki C; Kamei D; Tsuruta Y; Shimizu A; Shiohira S; Moriyama T; Itabashi M; Mochizuki T; Uchida K; Tsuchiya K; Hattori M; Nitta K
    Intern Med; 2012; 51(7):759-62. PubMed ID: 22466834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis.
    Yoshikawa N; Ito H; Akamatsu R; Hazikano H; Okada S; Matsuo T
    Arch Pathol Lab Med; 1986 May; 110(5):394-8. PubMed ID: 3754422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
    Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.
    Paik KH; Lee BH; Cho HY; Kang HG; Ha IS; Cheong HI; Jin DK; Moon KC; Choi Y
    Pediatr Nephrol; 2007 Mar; 22(3):389-95. PubMed ID: 17058050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.
    Suri M; Tran K; Sharma AP; Filler G; Grimmer J
    Int Urol Nephrol; 2008; 40(3):807-10. PubMed ID: 18491215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
    Marasà M; Cravedi P; Ruggiero B; Ruggenenti P
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25155494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal segmental glomerulosclerosis and renal transplantation.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrotic syndrome and rapid renal failure in autosomal dominant polycystic kidney disease.
    Murphy G; Tzamaloukas AH; Listrom MB; Gibel LJ; Smith SM; Gardner KD
    Am J Nephrol; 1990; 10(1):69-72. PubMed ID: 2343882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different targets for treating focal segmental glomerular sclerosis.
    Coppo R
    Contrib Nephrol; 2013; 181():84-90. PubMed ID: 23689570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New treatment strategies in idiopathic nephrotic syndrome.
    Ulinski T; Aoun B
    Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Collapsing glomerulopathy].
    Said JC; Letelier LM; González A; Escobillana C; Pisano R
    Rev Med Chil; 2012 Oct; 140(10):1342-6. PubMed ID: 23559294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.
    van Husen M; Kemper MJ
    Pediatr Nephrol; 2011 Jun; 26(6):881-92. PubMed ID: 21229269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Refractory nephrotic syndrome].
    Saito T
    Nihon Rinsho; 2004 Oct; 62(10):1794-9. PubMed ID: 15500120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and management of steroid-unresponsive nephrotic syndrome.
    Del Rio M; Kaskel F
    Curr Opin Pediatr; 2008 Apr; 20(2):151-6. PubMed ID: 18332710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Trials in FSGS: Past Challenges and New Trial Designs.
    Gipson D
    Semin Nephrol; 2016 Nov; 36(6):453-459. PubMed ID: 27987544
    [No Abstract]   [Full Text] [Related]  

  • 40. Focal glomerulosclerosis manifested with nephrotic syndrome.
    Tsau YK; Chen CH; Tsai WS; Sheu JN; Kuo PJ; Hsu HC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(6):401-7. PubMed ID: 2637621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.